Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -53.95% is 23% above its 5-year average of -70.35%, near the high end of its 5-year range (-833.20%–-26.48%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.88% above its 12-month average of -59.21%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -53.95%.
RETURN ON INVESTED CAPITAL (ROIC)
-53.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-59.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-86.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-70.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.88%
CURRENT VS 3Y AVG
+37.36%
CURRENT VS 5Y AVG
+23.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-51.36%
vs the sector median at left
PRF Technologies Ltd.
Market Cap
$70876.00
Return on Invested Capital (ROIC)
-53.95%
TTM Avg
-59.21%
3Y Avg
-86.14%
5Y Avg
-70.35%
Market Cap
$60201.00
Return on Invested Capital (ROIC)
-242.09%
TTM Avg
-168.38%
3Y Avg
-134.24%
5Y Avg
-96.72%
Market Cap
$96426.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-45.65%
3Y Avg
-31.03%
5Y Avg
-23.30%
Market Cap
$109693.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-1903.66%
3Y Avg
-964.53%
5Y Avg
-810.80%
Market Cap
$30997.00
Return on Invested Capital (ROIC)
-27.17%
TTM Avg
-13.97%
3Y Avg
-24.41%
5Y Avg
-14.32%
Market Cap
$29279.00
Return on Invested Capital (ROIC)
-116.42%
TTM Avg
-219.31%
3Y Avg
-171.50%
5Y Avg
-182.90%
Market Cap
$6077.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-57.80%
3Y Avg
-12.89%
5Y Avg
-12.89%
Market Cap
$246973.00
Return on Invested Capital (ROIC)
-152.82%
TTM Avg
-117.29%
3Y Avg
-102.27%
5Y Avg
-113.28%
Market Cap
$363900.00
Return on Invested Capital (ROIC)
-83.46%
TTM Avg
-94.98%
3Y Avg
-93.88%
5Y Avg
-93.88%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PRF Technologies Ltd. (PRFX) | $70876.00 | -53.95% | -59.21% | -86.14% | -70.35% |
| Akanda Corp. (AKAN)vs › | $60201.00 | -242.09% | -168.38% | -134.24% | -96.72% |
| Psyence Biomedical Ltd. (PBM)vs › | $96426.00 | N/A | -45.65% | -31.03% | -23.30% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109693.00 | N/A | -1903.66% | -964.53% | -810.80% |
| Zhongchao Inc. (ZCMD)vs › | $30997.00 | -27.17% | -13.97% | -24.41% | -14.32% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $29279.00 | -116.42% | -219.31% | -171.50% | -182.90% |
| NewGenIvf Group Limited (NIVF)vs › | $6077.00 | N/A | -57.80% | -12.89% | -12.89% |
| SciSparc Ltd. (SPRC)vs › | $246973.00 | -152.82% | -117.29% | -102.27% | -113.28% |
| Virax Biolabs Group Limited (VRAX)vs › | $363900.00 | -83.46% | -94.98% | -93.88% | -93.88% |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | -10.38% | -17.82% | -53.65% | -61.91% |
ROIC
-54.0%
ROE
-56.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -53.95% |
| 2026-03-31 | -53.45% |
| 2025-12-31 | -92.78% |
| 2025-09-30 | -48.41% |
| 2025-06-30 | -47.45% |
| 2025-03-31 | -118.22% |
| 2024-12-31 | -689.52% |
| 2024-09-30 | -833.20% |
| 2024-03-31 | -601.75% |
| 2023-12-31 | -127.45% |
| 2023-09-30 | -94.73% |
| 2023-06-30 | -138.78% |
| 2023-03-31 | -105.20% |
| 2022-12-31 | -78.74% |
| 2022-09-30 | -53.84% |
| 2022-06-30 | -45.51% |
| 2022-03-31 | -40.39% |
| 2021-12-31 | -39.35% |
| 2021-09-30 | -31.24% |
| 2021-06-30 | -26.48% |
| 2021-03-31 | -17.36% |
| 2020-12-31 | -9.92% |
| 2020-06-30 | -95.41% |
| 2019-12-31 | -69.04% |
| 2019-09-30 | -58.77% |
| 2019-06-30 | -562.79% |
| 2019-03-31 | -572.09% |
| 2018-12-31 | -793.65% |
